2008
DOI: 10.1016/j.jviromet.2008.05.023
|View full text |Cite
|
Sign up to set email alerts
|

A rapid point of care immunoswab assay for SARS-CoV detection

Abstract: The emergence of severe acute respiratory syndrome (SARS) resulted in several outbreaks worldwide. Early tests for diagnosis were not always conclusive in identifying a SARS suspected patient. Nucleocapsid protein (NP) is the most predominant virus derived structural protein which is shed in high amounts in serum and nasopharyngeal aspirate during the first week of infection. As part of such efforts, a simple, easy to use immunoswab method was developed by generating a panel of monoclonal antibodies (MAbs), Bi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
35
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 44 publications
(35 citation statements)
references
References 64 publications
(81 reference statements)
0
35
0
Order By: Relevance
“…Our laboratory has developed a highly sensitive, rapid, and simple BsMAbbased immunoswab assay for early detection of SARS-CoV (Kammila et al 2008). The assay is designed to detect the most abundant and conserved viral antigen nucleocapsid protein NP (Di et al 2005;Hiscox et al 1995;Lau et al 2004;Rota et al 2003;Suresh et al 2008) because its presence in different body fluids (serum, urine, nasopharyngeal aspirate, throat wash samples, and saliva) is suggestive of current infection.…”
Section: Severe Acute Respiratory Syndrome Coronavirusmentioning
confidence: 99%
See 2 more Smart Citations
“…Our laboratory has developed a highly sensitive, rapid, and simple BsMAbbased immunoswab assay for early detection of SARS-CoV (Kammila et al 2008). The assay is designed to detect the most abundant and conserved viral antigen nucleocapsid protein NP (Di et al 2005;Hiscox et al 1995;Lau et al 2004;Rota et al 2003;Suresh et al 2008) because its presence in different body fluids (serum, urine, nasopharyngeal aspirate, throat wash samples, and saliva) is suggestive of current infection.…”
Section: Severe Acute Respiratory Syndrome Coronavirusmentioning
confidence: 99%
“…The obtained anti-SARS-CoV Â anti-HRPO BsMAb was then purified by a novel, dual sequential affinity chromatography method (Protein-G column followed by m-aminophenyleboronic acid agarose column), which was developed by our laboratory ). In the immunoswab assay, easy-to-use swabs were first coated with anti-SARS-CoV monoclonal antibody to capture NP in the test sample followed by detection with BsMAb (Kammila et al 2008). Refer to Fig.…”
Section: Severe Acute Respiratory Syndrome Coronavirusmentioning
confidence: 99%
See 1 more Smart Citation
“…A large amount of IgY (100-200 mg/egg) can be extracted at a low cost from the egg yolks of hens immunized via a simple procedure (11). Many IgY-based applications are currently under development (12)(13)(14)(15). This study focused on its lower reactivity with protein A since IgY lacks a structurally different Fc region (16).…”
Section: Introductionmentioning
confidence: 99%
“…Using different combinations of MAb, bispecific MAb, and IgY, we have developed a pointof-care immunoswab assay with high sensitivity (9). Thus, our new MAbs could be useful reagents for diagnostics, as well as functional analysis of NP during infection.…”
mentioning
confidence: 99%